Featured Research

from universities, journals, and other organizations

New type of defibrillator for patients at risk for sudden cardiac death

Date:
April 28, 2014
Source:
Loyola University Health System
Summary:
A new device called a subcutaneous implantable cardioverter defibrillator (S-ICD) prevents sudden cardiac death with an electric shock. A conductor wire is implanted just under the skin, rather than going into the heart. In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart. In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart,

Subcutaneous implantable cardioverter defibrillator (S-ICD).
Credit: Boston Scientific

Loyola University Medical Center has begun offering patients a new type of implantable defibrillator that prevents sudden cardiac death with an electric shock to the heart.

The device is called a subcutaneous implantable cardioverter defibrillator (S-ICD). Unlike other implantable defibrillators, a conductor wire from the new device does not go into the heart. Rather, the wire (called a lead) is implanted over the heart, just under the skin. (Subcutaneous means under the skin.)

In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart, said Peter Santucci, MD, an associate professor in the Division of Cardiology and medical director of the Implant Device Program.

Loyola's first S-ICD patient is Stacey Tyranski, 36, of Huntley, Ill., who recently went into cardiac arrest at a health club, where she was taking a Zumba fitness class. An off-duty firefighter saved her life by administering CPR and an electric shock from an automated external defibrillator.

Tyranski was taken to a local hospital and then transferred to Loyola, where she was fitted with the new S-ICD.

"It makes me feel safe," she said.

Tyranski has a congenital heart condition called transposition of the great vessels. The two major vessels that carry blood away from the heart -- the aorta and the pulmonary artery -were switched (transposed). Tyranski had surgery to repair the defect when she was an infant. But the technique used at the time has increased her risk for irregular, life-threatening heartbeats called arrhythmias, said Joel Hardin, MD a specialist in congenital heart disease and an associate professor in Loyola's Division of Cardiology.

The Food and Drug Administration has approved the S-ICD, and the device is covered by Medicare. "It can protect patients from sudden cardiac death without putting leads into the heart," Santucci said.

In a standard defibrillator device known as a transvenous ICD, a primary lead is guided through a vein in the upper chest and into the right ventricle of the heart. But this was not possible in Tyranski's case, due to a completely obstructed vein that normally would allow a wire to enter the heart. She thus was a good candidate for a S-ICD.

While the battery of a transvenous ICD is implanted in the upper chest, the battery of a S-ICD is implanted on the side of the chest under the arm pit.

An implantable defibrillator is indicated for patients who have survived cardiac arrest or have risk factors for cardiac arrest, including significant cardiomyopathy, structural heart disease, heart failure and certain genetic heart rhythm abnormalities. An implantable defibrillator continually monitors the patient's heart rhythm. If the heart begins to beat dangerously fast or chaotically, the device restores normal rhythm with an electric shock.

In a significant percentage of patients, the lead of a defibrillator will need to be replaced after 10 or 20 years. Removing a lead from a transvenous ICD carries a small risk of perforating or tearing the heart wall. Removing a lead from a S-ICD carries a lower risk of serious complication, Santucci said. In a transvenous ICD, an infection from the lead going into the heart can be life-threatening. By contrast, if there is an infection from a lead of a subcutaneous ICD, the infection is unlikely to reach the bloodstream, Santucci said.

The S-ICD can be especially beneficial to patients who are at high risk for infections and for younger patients who likely will need to have leads replaced one or more times during their lifetimes.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "New type of defibrillator for patients at risk for sudden cardiac death." ScienceDaily. ScienceDaily, 28 April 2014. <www.sciencedaily.com/releases/2014/04/140428154840.htm>.
Loyola University Health System. (2014, April 28). New type of defibrillator for patients at risk for sudden cardiac death. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140428154840.htm
Loyola University Health System. "New type of defibrillator for patients at risk for sudden cardiac death." ScienceDaily. www.sciencedaily.com/releases/2014/04/140428154840.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins